Related Experiment Video

Updated: Aug 12, 2026

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

[Fibrinopeptide A and protein C in heart patients with acute coronary syndromes]

S Denchev, V Kamenov, R Ivanova

    Vutreshni Bolesti
    |January 1, 1988
    PubMed

    Insights

    This study found that fibrinopeptide A levels are significantly higher in patients with transmural myocardial infarction compared to non-transmural myocardial infarction, indicating a greater role for thrombosis in severe acute coronary syndromes.

    Area of Science:

    • Cardiology
    • Hematology
    • Biochemistry

    Context:

    • Acute coronary syndromes (ACS) are a spectrum of clinical conditions driven by plaque instability in coronary arteries.
    • Thrombosis plays a critical role in the pathophysiology of ACS, leading to myocardial infarction.
    • Differentiating between transmural and non-transmural myocardial infarction is crucial for treatment strategies.

    Purpose:

    • To investigate the role of thrombosis in acute coronary syndromes by measuring blood levels of fibrinopeptide A and protein C.
    • To compare these markers in patients with transmural versus non-transmural myocardial infarction.
    • To assess the diagnostic utility of these markers in acute coronary syndromes.

    Summary:

    • Enzyme-immune tests were performed on 48 ACS patients (27 transmural MI, 21 non-transmural MI) within 72 hours of symptom onset.
    • Fibrinopeptide A levels were significantly higher (p<0.005) in transmural MI (6.09 ± 3.49 ng/ml) than non-transmural MI (3.49 ± 1.7 ng/ml).
    • Protein C levels were lower in transmural MI (65.3 ± 8.0%) compared to non-transmural MI (76.3 ± 8.3%), also showing statistical significance (p<0.005).

    Impact:

    • These findings suggest that elevated fibrinopeptide A levels are indicative of increased thrombotic activity in transmural myocardial infarction.
    • The study highlights the potential of fibrinopeptide A and protein C as biomarkers for assessing thrombotic burden in ACS.
    • Understanding these thrombotic markers can aid in risk stratification and guide therapeutic interventions for acute coronary syndromes.

    More Related Videos

    Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures10:01

    Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

    Published on: March 12, 2018

    Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

    Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

    Published on: May 28, 2019

    Related Concept Videos

    Clot Retraction and Fibrinolysis01:16

    Clot Retraction and Fibrinolysis

    After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

    Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
    These markers indicate stress or strain on the heart muscle:
    Natriuretic Peptides (BNP)
    Cardiac myocytes produce these hormones in response to ventricular stretching...
    Acute Coronary Syndrome I: Introduction01:30

    Acute Coronary Syndrome I: Introduction

    Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
    Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

    Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

    The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
    Acute Coronary Syndrome III: Diagnostic Studies01:30

    Acute Coronary Syndrome III: Diagnostic Studies

    Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
    Acute Coronary Syndrome IV: Interprofessional Care01:28

    Acute Coronary Syndrome IV: Interprofessional Care

    IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...